Shanghai, China

Hualiang Jiang

USPTO Granted Patents = 41 

 

Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 17(Granted Patents)


Company Filing History:

goldMedal39 out of 3,086 
 
Chinese Academy of Sciences
 patents
silverMedal5 out of 15 
 
Topharman Shanghai Co., Ltd.
 patents
bronzeMedal3 out of 8 
 
Wigen Biomedicine Technology (shanghai) Co., Ltd.
 patents
43 out of 5 
 
Suzhou Vigonvita Life Sciences Co., Ltd.
 patents
52 out of 4 
 
Topharman Shandong Co., Ltd.
 patents
62 out of 2 
 
Vigonvita Life Sciences Co., Ltd.
 patents
72 out of 2 
 
Suzhou Suplead Life Sciences Co., Ltd.
 patents
82 out of 125 
 
East China University of Science and Technology
 patents
91 out of 1 
 
Kingsound & Partner
 patent
101 out of 5 
 
Cisen Pharmaceutical Co., Ltd.
 patents
111 out of 1 
 
Shanghai Institute of Materia Medica, Cas
 patent
121 out of 1 
 
Shanghai Institute of Materia Medica, Chines Academy of Sciences
 patent
131 out of 207 
 
Fudan University
 patents
141 out of 1 
 
Suzhou Institute of Materia Medica
 patent
151 out of 14 
 
Yunnan University
 patents
161 out of 1 
 
Nanjing Pailexing Pharmaceutical Technology Ltd.
 patent
171 out of 1 
 
Shanghai Lead Discovery Pharmaceuticals Limited Company
 patent
where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...
Loading Chart...
41 patents (USPTO):

Title: Hualiang Jiang: Pioneering the Field of Pharmaceutical Innovations in Shanghai

Introduction

Hualiang Jiang is a renowned inventor based in Shanghai, China, and holds an impressive portfolio of 40 patents. His work primarily focuses on the development of innovative pharmaceutical compounds and their applications in treating various diseases, showcasing his significant contributions to the biomedical field.

Latest Patents

Among Hualiang Jiang's latest patents are two notable inventions. The first patent details a histone acetyltransferase (HAT) inhibitor, which includes a range of compounds, such as stereoisomers, enantiomers, and polymorphs. This invention emphasizes its therapeutic potential in treating HAT-related diseases.

The second patent introduces a ketoamide compound and outlines its preparation method and pharmaceutical composition. This compound demonstrates efficacy in inhibiting viruses like the coronavirus and Ebola, indicating its potential role in preventing and treating diseases related to these pathogens.

Career Highlights

Hualiang Jiang has made significant strides in his career, being associated with prominent institutions and companies. He has worked at the Shanghai Institute of Materia Medica, which is part of the Chinese Academy of Sciences, as well as at Topharman Shanghai Co., Ltd. These positions have enabled him to collaborate on various innovative projects and further his research in pharmaceutical sciences.

Collaborations

Throughout his career, Hualiang Jiang has teamed up with several talented individuals. Notable among his collaborators are Kaixian Chen and Hong Tao Liu. Their combined expertise has undoubtedly contributed to the successful development of Jiang's impactful inventions.

Conclusion

Hualiang Jiang stands out as a significant figure in the realm of pharmaceuticals, with an impressive number of patents that exemplify his commitment to innovation. His work not only enhances our understanding of disease treatment but also underscores the importance of collaboration in scientific research. As he continues to develop novel compounds, Hualiang Jiang is likely to remain a key player in the pharmaceutical industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…